08:46 AM EDT, 05/01/2024 (MT Newswires) -- Health care stocks were leaning lower pre-bell Wednesday, with the Health Care Select Sector SPDR Fund (XLV) down 0.1% and the iShares Biotechnology ETF (IBB) recently 0.4% lower.

Johnson & Johnson ( JNJ ) was up more than 2% after it announced a proposed plan by its LLT Management unit for the final resolution of all current and future claims tied to ovarian cancer stemming from cosmetic talc litigation against it and its affiliates in the US.